Get the Stockscreener App
1.59
3.25%
+0.05
180 Life Sciences Corp stock is currently priced at $1.59, with a 24-hour trading volume of 122.69K.
It has seen a +3.25% increased in the last 24 hours and a -21.29% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $1.56 pivot point. If it approaches the $1.63 resistance level, significant changes may occur.
Previous Close:
$1.54
Open:
$1.664
24h Volume:
122.69K
Market Cap:
$1.50M
Revenue:
-
Net Income/Loss:
$-19.94M
P/E Ratio:
-0.0664
EPS:
-23.95
Net Cash Flow:
$-10.92M
1W Performance:
-8.62%
1M Performance:
-21.29%
6M Performance:
+691.04%
1Y Performance:
+37.07%
1D Range:
$1.53
$1.8499
52W Range:
$0.1501
$4.3899
180 Life Sciences Corp Stock (ATNF) Company Profile
Name
180 Life Sciences Corp
Sector
Industry
Phone
650 507 0669
Address
Building 4, 3000 El Camino Real Suite 200, Palo Alto
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-15-21 | Initiated | Maxim Group | Buy |
180 Life Sciences Corp Stock (ATNF) Latest News
Biopharma Layoff Tracker 2024: Barinthus, Agilent, BMS and More Cut Staff - BioSpace
BioSpace
Biopharma Layoff Tracker 2024: Barinthus, Agilent, BMS and More Cut Staff - BioSpace
BioSpace
Biopharma Layoff Tracker 2024: Barinthus, Agilent, BMS and More Cut Staff - BioSpace
BioSpace
Biopharma Layoff Tracker 2024: Barinthus, Agilent, BMS and More Cut Staff - BioSpace
BioSpace
Biopharma Layoff Tracker 2024: Barinthus, Agilent, BMS and More Cut Staff - BioSpace
BioSpace
Biopharma Layoff Tracker 2024: Agilent, BMS, Takeda and More Cut Staff - BioSpace
BioSpace
180 Life Sciences Corp Stock (ATNF) Financials Data
180 Life Sciences Corp (ATNF) Net Income 2024
ATNF net income (TTM) was -$19.94 million for the quarter ending December 31, 2023, a +48.52% increase year-over-year.
180 Life Sciences Corp (ATNF) Cash Flow 2024
ATNF recorded a free cash flow (TTM) of -$10.92 million for the quarter ending December 31, 2023, a +9.94% increase year-over-year.
180 Life Sciences Corp (ATNF) Earnings per Share 2024
ATNF earnings per share (TTM) was -$64.27 for the quarter ending December 31, 2023, a +82.40% growth year-over-year.
About 180 Life Sciences Corp
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
0.37%
0.64%
Cap:
|
Volume (24h):